Literature DB >> 17101820

Docosahexaenoic acid and Alzheimer disease.

Martha Clare Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17101820     DOI： 10.1001/archneur.63.11.1527

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  3 in total

1.  Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies.

Authors:  Q Gao; M Niti; L Feng; K B Yap; Tze Pin Ng
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

2.  Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood.

Authors:  Matthew F Muldoon; Christopher M Ryan; Lei Sheu; Jeffrey K Yao; Sarah M Conklin; Stephen B Manuck
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

3.  Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain.

Authors:  Paul H Axelsen; Robert C Murphy
Journal:  J Lipid Res       Date:  2009-09-18       Impact factor: 5.922
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.